Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IdeaSphere acquisition

This article was originally published in The Tan Sheet

Executive Summary

IdeaSphere looks to strengthen and expand its international healthcare business through its acquisition of Boehringer Ingelheim's Pharmaton multivitamin business, the brand management firm states Aug. 25 in a joint release announcing the deal. The purchase "complements not only our geographical strength in North America with attractive market positions but also provides access to other strategic markets for IdeaSphere in Europe, the Middle East, Latin America and Asia. Moreover, both of our companies emphasize science-based medicines," said IdeaSphere President and COO Mark Fox. Twinlab-owner IdeaSphere acquired Metabolife in November and received worldwide licensing rights to Weil Nutritional Supplements in January (1"The Tan Sheet," Nov. 14, 2005, In Brief and 2"The Tan Sheet, Jan. 23, 2006, In Brief). "Boehringer Ingelheim will continue to strengthen is Consumer Healthcare business by further building up the flagship and international core brands, e.g., Dulcolax, Buscopan and Antistax," Chairman of the Board of Managing Directors Alessandro Banchi noted in the release...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel